|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07K 14/435 | (2006.01) |
| (11) | Patento numeris | 3564258 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19162848.6 |
| Europos patento paraiškos padavimo data | 2013-09-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data | 2021-08-25 |
| (30) | Numeris | Data | Šalis |
| 201261700697 P | 2012-09-13 | US | |
| 201361780005 P | 2013-03-13 | US |
| (72) |
CLOAD, Sharon, US
ENGLE, Linda, US
LIPOVSEK, Dasa, US
MADIREDDI, Malavi, US
RAKESTRAW, Ginger, Chao, US
SWAIN, Joanna F., US
ZHAO, Wenjun, US
WEI, Hui, US
YAMNIUK, Aaron, P., US
KOZHICH, Alexander, T., US
RAMAMURTHY, Vidhyashankar, IN
CORBETT, Martin, J., US
KRYSTEK, Stanley, Richard, Jr., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Karkasiniai domeniniai baltymai fibronektino pagrindu, kurie jungiasi su miostatinu |
| FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-07-24 | 13 | 289.00 EUR |
| 2026-09-12 |